SEC Filing Analysis: Aramark (ARMK)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The EVP and CFO, James J. Tarangelo, received 99.511 shares as dividend equivalent rights on previously granted stock units, a routine and non-discretionary event with a transaction value of $0.
• Market Impact: Neutral. This transaction is immaterial and has no bearing on market sentiment or trading activity.

Company Information

Field	Value
Company	Aramark
Ticker Symbol	ARMK
CIK	0001584509
Industry	RETAIL-EATING PLACES

Insider Information

Field	Value
Name	Tarangelo James J.
CIK	0001689847
Title/Position	EVP and CFO
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	A
Security Type	Common Stock
Shares Involved	99.511
Price Per Share	$0.00
Total Value	$0
Shares Owned After	61,359.989
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	99.511
% of Shares Outstanding	Not Available
Post-Transaction Ownership	61,359.989 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it entirely immaterial to Aramark's $10.00 billion market capitalization.
• Transaction Significance: This is a non-event from a trading perspective. The acquisition is a result of dividend payments on existing equity awards, not an open-market decision by the insider.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a non-discretionary grant of dividend equivalents with zero cash value. It does not signal any change in insider sentiment or company outlook.

Volume & Sentiment

• Expected Volume Impact: None. This type of transaction does not influence trading volume.
• Sentiment Indicator: Neutral. The filing is purely administrative and carries no bullish or bearish signals.

Additional Context

Transaction Notes

• Special Circumstances: As per footnote 1, the shares represent dividend equivalent rights accrued on existing restricted stock units (RSUs) and performance stock units (PSUs). These vest on the same schedule as the underlying awards.